Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name PVT1
   Synonyms PVT1, LINC00079, MYC, NCRNA00079, onco-lncRNA-100, MIR1204HG
   Region GRCh38_8:127794533-128101253    Sequence
   Ensembl ENSG00000249859
   RefSeq NR_003367
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name glioma
   ICD-0-3  M9380/3
   Methods Western blot, Luciferase reporter assay etc.
   Sample cell line (HUVEC)
   Expression Pattern differential expression
   Function Description

PVT1 affected cell proliferation, migration and in vitro vascular tube formation of HUVECs.In addition,it was determined that PVT1 was able to bind and degrade miR-26b to promote connective tissue growth factor (CTGF) and angiopoietin 2 (ANGPT2) expression.miR-26b was also identified to have a suppressive role in cell proliferation,migration and in vitro vascular tube formation of HUVECs via binding 3'-UTR regions and downregulating CTGF and ANGPT2 expression levels.PVT1 was important in angiogenesis of vascular endothelial cell as ceRNA to bind and degrade miR-26b,which expanded the current understanding of PVT1 as ceRNA to regulate biological processes.

   Pubmed ID 29620147
   Year 2018
   Title lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR-26b to activate CTGF/ANGPT2.
   External Links
   Links for  PVT1 GenBank       HGNC       lncrnadb       Noncode
   Links for  glioma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.